JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-10-05 ms8000000524560535 来自重庆

有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受

23 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-12-13 究极奥美拉唑来自广西

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;生信加细胞功能实验
经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！
Submission is in publishing and rights
12 Dec 2023
Peer review
Submission status Date
Submission accepted
12 Dec 2023
Submission under peer review
06 Dec 2023
Submission passed technical check
06 Dec 2023
Revision received
03 Dec 2023
Submission under peer review
15 Nov 2023
Submission passed technical check
15 Nov 2023
Revision received
14 Nov 2023
Submission under peer review
05 Sep 2023
Submission passed technical check
05 Sep 2023
Revision received
04 Sep 2023
Submission under peer review
05 Aug 2023
Technical check
Submission status Date
Submission passed technical check
05 Aug 2023
Submission is under technical check
04 Aug 2023
Submission received
Submission status Date
Submission received
04 Aug 2023

26 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-10-19 ms3000000403158145 来自河南省

投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？

24 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2024-03-01 小叶子199 来自北京

想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2024-02-26 ms8000002119425457 来自山西省

偏重的研究方向：肿瘤;生信
经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊

19 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-04-19 王子安那来自天津

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床
经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！

40 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2022-11-25 ms7000002055690251 来自东京都

偏重的研究方向：肿瘤
经验分享：11.16 submissions
11.17 Technical check in progress/ ready to be assigned to an editor
11.18 assigned editor
11.24 10 reviewers invited/ two reviewers accepted
11.25 1 Reviewer report received

58 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-08-04 ms1000001224469901 来自河南省

审稿速度:1.0 | 投稿命中率:95.0
经验分享：2023.07.13投稿
2023.07.23返修
2023.07.26上传返修稿
2023.08.04接受，整个过程20天，效率极高的杂志。

42 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2024-01-27 ms8000001112033195 来自安徽省

偏重的研究方向：肿瘤;基础
经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊

19 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2160993, encodeId=8fa32160993d6, content=有兄弟出现这种情况吗，技术审查通过后，两个审稿人接受，时间频繁变动，最后三个审稿人接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c31b6158531, createdName=ms8000000524560535, createdTime=Thu Oct 05 08:02:49 CST 2023, time=2023-10-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174798, encodeId=c25321e4798cc, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信加细胞功能实验 经验分享：历时四个月多月，除去期刊改革耽误2个月左右，整体还算比较顺利，希望各位朋友多中文章！！！ Submission is in publishing and rights 12 Dec 2023 Peer review Submission status Date Submission accepted 12 Dec 2023 Submission under peer review 06 Dec 2023 Submission passed technical check 06 Dec 2023 Revision received 03 Dec 2023 Submission under peer review 15 Nov 2023 Submission passed technical check 15 Nov 2023 Revision received 14 Nov 2023 Submission under peer review 05 Sep 2023 Submission passed technical check 05 Sep 2023 Revision received 04 Sep 2023 Submission under peer review 05 Aug 2023 Technical check Submission status Date Submission passed technical check 05 Aug 2023 Submission is under technical check 04 Aug 2023 Submission received Submission status Date Submission received 04 Aug 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=912a8743402, createdName=究极奥美拉唑, createdTime=Wed Dec 13 20:39:35 CST 2023, time=2023-12-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2163678, encodeId=e37621636e8ac, content=投稿当天很快就是“We will now find the most suitable editor to manage the next steps of your submission”，现在一周了还是这样，这个杂志不是出了名的快吗？现在怎么变慢了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8dd8435452, createdName=ms3000000403158145, createdTime=Thu Oct 19 09:35:30 CST 2023, time=2023-10-19, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2190452, encodeId=6d532190452bc, content=想请教一下大佬，这个杂志怎么生成pdf，我上传了一遍，没点submission，第二次登进去啥也没保存。后来又上传一遍，点submission，结果直接提交了，连检查一遍都没有，有点崩溃！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dba58746794, createdName=小叶子199, createdTime=Fri Mar 01 17:44:03 CST 2024, time=2024-03-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189539, encodeId=b53f218953953, content=偏重的研究方向：肿瘤;生信 经验分享：感觉非常非常不靠谱，一开始发邮件接受了，然后过了一会儿又发邮件说是发错了，给拒绝了。我是第一次这么遇到，太不靠谱了啊这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1868855082, createdName=ms8000002119425457, createdTime=Mon Feb 26 22:58:38 CST 2024, time=2024-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2127011, encodeId=7336212e011e9, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床 经验分享：6号投稿，8号接收，19号在线发表，感谢编辑和审稿人，非常高效！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2675544063, createdName=王子安那, createdTime=Wed Apr 19 12:29:46 CST 2023, time=2023-04-19, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2102655, encodeId=ad512102655db, content=偏重的研究方向：肿瘤 经验分享：11.16 submissions 11.17 Technical check in progress/ ready to be assigned to an editor 11.18 assigned editor 11.24 10 reviewers invited/ two reviewers accepted 11.25 1 Reviewer report received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84dc8360635, createdName=ms7000002055690251, createdTime=Fri Nov 25 22:06:27 CST 2022, time=2022-11-25, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2151334, encodeId=ea63215133452, content=审稿速度:1.0 | 投稿命中率:95.0 经验分享：2023.07.13投稿 2023.07.23返修 2023.07.26上传返修稿 2023.08.04接受，整个过程20天，效率极高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5256534162, createdName=ms1000001224469901, createdTime=Fri Aug 04 22:14:11 CST 2023, time=2023-08-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2184341, encodeId=1c702184341fc, content=偏重的研究方向：肿瘤;基础 经验分享：有没有投过的前辈清楚，6个审稿人邀请16天了，也没人接受审稿，后续会怎么样，做的方向很大众化，感觉审稿人应该也不难找啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=52758133520, createdName=ms8000001112033195, createdTime=Sat Jan 27 22:14:24 CST 2024, time=2024-01-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2145621, encodeId=89262145621c2, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤;生信 经验分享：肿瘤生信加了qPCR Submission status Date 29 Jun 2023 Submission accepted 29 Jun 2023 Submission under peer review 24 May 2023 Submission passed technical check 24 May 2023 Submission is under technical check 23 May 2023 Submission received 23 May 2023 一个月直接接收没有返修...现在还是懵的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=acc08219218, createdName=ms6000000533964556, createdTime=Fri Jun 30 09:58:44 CST 2023, time=2023-06-30, status=1, ipAttribution=山东省)]

2023-06-30 ms6000000533964556 来自山东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤;生信
经验分享：肿瘤生信加了qPCR
Submission status Date
29 Jun 2023

Submission accepted
29 Jun 2023

Submission under peer review
24 May 2023

Submission passed technical check
24 May 2023

Submission is under technical check
23 May 2023

Submission received
23 May 2023

一个月直接接收没有返修...现在还是懵的

50 18

展开18条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务